Total Payments
$1,468
2024 Payments
$182.97
Companies
18
Transactions
78
Medicare Patients
11,805
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$1,287 (87.6%)
Education$181.49 (12.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,287 | 74 | 87.6% |
| Education | $181.49 | 4 | 12.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $690.24 | 40 | $0 (2024) |
| UROVANT SCIENCES INC | $167.24 | 9 | $0 (2022) |
| Coloplast Corp | $104.94 | 4 | $0 (2023) |
| Endo Pharmaceuticals Inc. | $71.58 | 2 | $0 (2019) |
| C. R. Bard, Inc. & Subsidiaries | $68.72 | 3 | $0 (2024) |
| UROGEN PHARMA, INC. | $44.93 | 2 | $0 (2024) |
| Rochester Medical Corporation | $41.83 | 2 | $0 (2022) |
| Hollister Incorporated | $40.20 | 2 | $0 (2023) |
| Amgen Inc. | $36.19 | 2 | $0 (2023) |
| PROGENICS PHARMACEUTICALS, INC. | $33.41 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $182.97 | 10 | Astellas Pharma US Inc ($61.85) |
| 2023 | $286.98 | 15 | Astellas Pharma US Inc ($97.25) |
| 2022 | $333.70 | 17 | Astellas Pharma US Inc ($144.34) |
| 2021 | $290.35 | 12 | Astellas Pharma US Inc ($139.63) |
| 2020 | $59.25 | 4 | Astellas Pharma US Inc ($45.39) |
| 2019 | $72.24 | 5 | Astellas Pharma US Inc ($42.46) |
| 2018 | $84.70 | 3 | Endo Pharmaceuticals Inc. ($52.86) |
| 2017 | $158.03 | 12 | Astellas Pharma US Inc ($142.11) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | C. R. Bard, Inc. & Subsidiaries | — | Food and Beverage | In-kind items and services | $27.10 | General |
| 11/18/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: ONCOLOGY | ||||||
| 08/15/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: UROTHELIAL CANCER | ||||||
| 07/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Diabetes | ||||||
| 05/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Biological | ||||||
| 03/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Biological | ||||||
| 02/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Biological | ||||||
| 02/01/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 01/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Biological | ||||||
| 12/11/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Biological | ||||||
| 11/16/2023 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/23/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Biological | ||||||
| 10/19/2023 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: Urology | ||||||
| 09/20/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Biological | ||||||
| 08/14/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Biological | ||||||
| 07/24/2023 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Bone Health | ||||||
| 07/20/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Diabetes | ||||||
| 07/19/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Urology | ||||||
| 07/11/2023 | Laborie Medical Technologies Corp. | — | Food and Beverage | Cash or cash equivalent | $23.95 | General |
| 06/19/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Biological | ||||||
| 04/12/2023 | Coloplast Corp | Porges Coloplast (Device) | Food and Beverage | In-kind items and services | $33.96 | General |
| Category: Endourology | ||||||
| 03/02/2023 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Bone Health | ||||||
| 03/01/2023 | Hollister Incorporated | Infyna Chic (Device) | Food and Beverage | Cash or cash equivalent | $15.88 | General |
| Category: Continence Care | ||||||
| 02/06/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,860 | 4,575 | $759,278 | $262,314 |
| 2022 | 27 | 2,520 | 4,207 | $666,484 | $227,465 |
| 2021 | 21 | 2,937 | 4,886 | $716,653 | $260,232 |
| 2020 | 33 | 3,488 | 5,878 | $912,783 | $322,902 |
Total Patients
11,805
Total Services
19,546
Medicare Billing
$1.1M
Procedure Codes
109
All Medicare Procedures & Services
109 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 626 | 897 | $221,632 | $75,279 | 34.0% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 52 | 476 | $192,572 | $62,747 | 32.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 131 | 144 | $66,384 | $24,699 | 37.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 215 | 268 | $47,168 | $16,509 | 35.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 68 | 163 | $22,820 | $9,962 | 43.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 67 | 73 | $28,397 | $9,329 | 32.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 47 | 67 | $23,249 | $8,670 | 37.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 65 | 65 | $21,052 | $7,257 | 34.5% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 14 | 16 | $18,496 | $6,704 | 36.2% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 16 | 18 | $14,886 | $5,833 | 39.2% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 217 | 270 | $13,500 | $4,850 | 35.9% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 29 | 29 | $13,543 | $4,813 | 35.5% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 18 | 19 | $11,685 | $4,358 | 37.3% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 737 | 1,267 | $12,670 | $3,927 | 31.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 22 | 22 | $9,504 | $3,556 | 37.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 29 | 29 | $7,511 | $2,905 | 38.7% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 17 | 18 | $9,440 | $2,074 | 22.0% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 52 | 81 | $5,022 | $1,860 | 37.0% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 11 | 38 | $4,522 | $1,616 | 35.7% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 29 | 29 | $3,248 | $1,278 | 39.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 127 | 147 | $3,570 | $1,035 | 29.0% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2023 | 50 | 51 | $2,550 | $919.02 | 36.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 13 | 14 | $1,960 | $878.78 | 44.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 55 | 59 | $1,820 | $628.32 | 34.5% |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | Office | 2023 | 36 | 40 | $321.00 | $257.88 | 80.3% |
About Dr. Jon Johnson, MD
Dr. Jon Johnson, MD is a Urology healthcare provider based in Monroe, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629014626.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jon Johnson, MD has received a total of $1,468 in payments from pharmaceutical and medical device companies, with $182.97 received in 2024. These payments were reported across 78 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,287).
As a Medicare-enrolled provider, Johnson has provided services to 11,805 Medicare beneficiaries, totaling 19,546 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 109 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Monroe, LA
- Active Since 06/20/2006
- Last Updated 06/12/2019
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1629014626
Products in Payments
- Myrbetriq (Drug) $237.24
- GEMTESA (Drug) $167.24
- XTANDI (Drug) $144.44
- Veozah (Drug) $143.31
- XIAFLEX (Biological) $71.58
- JELMYTO (Drug) $44.93
- MYRBETRIQ (Drug) $40.74
- Infyna Chic (Device) $40.20
- Prolia (Biological) $36.19
- Porges Coloplast (Device) $33.96
- PYLARIFY (Drug) $33.41
- SpeediCath (Device) $29.75
- Bard Urinary Drainage Bag (Device) $25.70
- PROLARIS (Device) $24.31
- ImaJin (Device) $21.95
- NOCDURNA (Drug) $20.60
- Isiris (Device) $19.28
- ERLEADA (Drug) $17.27
- BMD-Bard Skylite (Device) $15.92
- Ozempic (Drug) $15.40
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Monroe
Dr. Ashwin Shah, Md, MD
Urology — Payments: $37,238
Urology $37,238
Dr. David Kang, M.d, M.D
Urology — Payments: $14,178
Urology $14,178
Daniel Linn, Md, MD
Urology — Payments: $13,864
Urology $13,864
Odell Dean, M.d, M.D
Urology — Payments: $7,606
Urology $7,606
Robert Humble, Md, MD
Urology — Payments: $4,042
Urology $4,042
Dr. Ngii Tazeh, M.d., Ph.d, M.D., PH.D
Urology — Payments: $3,475
Urology $3,475